Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study
Ho, Gwo-Fuang, Chai, Chee-Shee, Alip, Adlinda, Wahid, Mohd Ibrahim A, Abdullah, Matin Mellor, Foo, Yoke-Ching, How, Soon-Hin, Zaatar, Adel, Lam, Kai-Seng, Leong, Kin-Wah, Low, John-Seng-Hooi, Yusof, Mastura Md, Lee, Erica Chai-Yong, Toh, Yok-Yong, Liam, Chong-Kin
Published in BMC cancer (09.09.2019)
Published in BMC cancer (09.09.2019)
Get full text
Journal Article
A phase II, single-arm, open label, Simon two-stage study of pembrolizumab in patients with metastatic HER2-negative breast cancer: Evaluation of impact of germline variants in APOBEC3B (AUROR)
Ho, Gwo Fuang, Lee, Soo-Chin, Lim, Joanna, Bustam, Anita Zarina, Lim, Siew Eng, Saad, Marniza, Ow, Samuel Guan Wei, Ngoi, Natalie, Abdul Satar, Nur Fadhlina, Malik, Rozita Abdul, Alip, Adlinda, Law, Kian Boon, Toh, Yok Yong, Pan, Jia Wern, Teo, Soo Hwang
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article